An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

NCT01887938 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Metachromatic Leukodystrophy (MLD)

Interventions

BIOLOGICAL: HGT-1110

Sponsor

Shire

Collaborators

[object Object]